After the coronavirus pandemic entered our lives in March 2020, we were not able to see our family and friends for a long time. We were estranged from our favorite social activities. Hundreds of thousands of people lost their lives, and more were hospitalized. Not to mention the depression and the psychological destruction it created. But in this period, we did not feel the bad impacts only because of the coronavirus.
Alcohol and drug consumption has increased. Drug-related overdose deaths showed a rapid increase each month.This was one of the main problems in many parts of the world, especially in the USA, for many years. During the COVID-19 pandemic, a further substantial increase in drug overdose deaths was reported in the USA, primarily driven by rapid increases in overdose deaths involving synthetic opioids. Data from the Centers for Disease Control and Prevention (CDC) shows that overdose deaths rose 28.5% in the 12 months ending this past April.The number of deaths from drugs has now surpassed those from guns, car crashes and the flu in the US.And over 2,300 people died due to drug overdose from 2017-19 in India, according to the data by the National Crime Records Bureau.
However, the medicine called Sublocade, developed by Indivior Solutions Inc, offers a pioneering treatment in opioid addiction. Vishal Kalia, Senior Vice President of Indivior Solutions Inc, who has great experience in the marketing industry, is behind all the commercial strategies of the company to bring this medicine national and international reputation. Kalia carries out one of the most important marketing strategies in the world with the opioid medicine. It is expected to generate a budget of $1 billion for the company over the next five years.